1 Acute Migraine Drugs Market Overview 1.1 Acute Migraine Drugs Product Overview 1.2 Acute Migraine Drugs Market Segment by Type 1.2.1 Triptans 1.2.2 NSAIDs 1.2.3 Others 1.3 Global Acute Migraine Drugs Market Size by Type 1.3.1 Global Acute Migraine Drugs Market Size Overview by Type (2016-2027) 1.3.2 Global Acute Migraine Drugs Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Acute Migraine Drugs Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Acute Migraine Drugs Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Acute Migraine Drugs Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Acute Migraine Drugs Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Acute Migraine Drugs Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Acute Migraine Drugs Sales Breakdown by Type (2016-2021) 1.4.2 Europe Acute Migraine Drugs Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Acute Migraine Drugs Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Acute Migraine Drugs Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Acute Migraine Drugs Sales Breakdown by Type (2016-2021) 2 Global Acute Migraine Drugs Market Competition by Company 2.1 Global Top Players by Acute Migraine Drugs Sales (2016-2021) 2.2 Global Top Players by Acute Migraine Drugs Revenue (2016-2021) 2.3 Global Top Players Acute Migraine Drugs Price (2016-2021) 2.4 Global Top Manufacturers Acute Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type 2.5 Acute Migraine Drugs Market Competitive Situation and Trends 2.5.1 Acute Migraine Drugs Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Acute Migraine Drugs Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020) 2.7 Date of Key Manufacturers Enter into Acute Migraine Drugs Market 2.8 Key Manufacturers Acute Migraine Drugs Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Acute Migraine Drugs Status and Outlook by Region 3.1 Global Acute Migraine Drugs Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Acute Migraine Drugs Historic Market Size by Region 3.2.1 Global Acute Migraine Drugs Sales in Volume by Region (2016-2021) 3.2.2 Global Acute Migraine Drugs Sales in Value by Region (2016-2021) 3.2.3 Global Acute Migraine Drugs Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Acute Migraine Drugs Forecasted Market Size by Region 3.3.1 Global Acute Migraine Drugs Sales in Volume by Region (2022-2027) 3.3.2 Global Acute Migraine Drugs Sales in Value by Region (2022-2027) 3.3.3 Global Acute Migraine Drugs Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Acute Migraine Drugs by Application 4.1 Acute Migraine Drugs Market Segment by Application 4.1.1 Hospital Pharmacies 4.1.2 Drug Stores 4.2 Global Acute Migraine Drugs Market Size by Application 4.2.1 Global Acute Migraine Drugs Market Size Overview by Application (2016-2027) 4.2.2 Global Acute Migraine Drugs Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Acute Migraine Drugs Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Acute Migraine Drugs Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Acute Migraine Drugs Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Acute Migraine Drugs Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Acute Migraine Drugs Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Acute Migraine Drugs Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Acute Migraine Drugs Sales Breakdown by Application (2016-2021) 4.3.2 Europe Acute Migraine Drugs Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Acute Migraine Drugs Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Acute Migraine Drugs Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Acute Migraine Drugs Sales Breakdown by Application (2016-2021) 5 North America Acute Migraine Drugs by Country 5.1 North America Acute Migraine Drugs Historic Market Size by Country 5.1.1 North America Acute Migraine Drugs Sales in Volume by Country (2016-2021) 5.1.2 North America Acute Migraine Drugs Sales in Value by Country (2016-2021) 5.2 North America Acute Migraine Drugs Forecasted Market Size by Country 5.2.1 North America Acute Migraine Drugs Sales in Volume by Country (2022-2027) 5.2.2 North America Acute Migraine Drugs Sales in Value by Country (2022-2027) 6 Europe Acute Migraine Drugs by Country 6.1 Europe Acute Migraine Drugs Historic Market Size by Country 6.1.1 Europe Acute Migraine Drugs Sales in Volume by Country (2016-2021) 6.1.2 Europe Acute Migraine Drugs Sales in Value by Country (2016-2021) 6.2 Europe Acute Migraine Drugs Forecasted Market Size by Country 6.2.1 Europe Acute Migraine Drugs Sales in Volume by Country (2022-2027) 6.2.2 Europe Acute Migraine Drugs Sales in Value by Country (2022-2027) 7 Asia-Pacific Acute Migraine Drugs by Region 7.1 Asia-Pacific Acute Migraine Drugs Historic Market Size by Region 7.1.1 Asia-Pacific Acute Migraine Drugs Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Acute Migraine Drugs Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Acute Migraine Drugs Forecasted Market Size by Region 7.2.1 Asia-Pacific Acute Migraine Drugs Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Acute Migraine Drugs Sales in Value by Region (2022-2027) 8 Latin America Acute Migraine Drugs by Country 8.1 Latin America Acute Migraine Drugs Historic Market Size by Country 8.1.1 Latin America Acute Migraine Drugs Sales in Volume by Country (2016-2021) 8.1.2 Latin America Acute Migraine Drugs Sales in Value by Country (2016-2021) 8.2 Latin America Acute Migraine Drugs Forecasted Market Size by Country 8.2.1 Latin America Acute Migraine Drugs Sales in Volume by Country (2022-2027) 8.2.2 Latin America Acute Migraine Drugs Sales in Value by Country (2022-2027) 9 Middle East and Africa Acute Migraine Drugs by Country 9.1 Middle East and Africa Acute Migraine Drugs Historic Market Size by Country 9.1.1 Middle East and Africa Acute Migraine Drugs Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Acute Migraine Drugs Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Acute Migraine Drugs Forecasted Market Size by Country 9.2.1 Middle East and Africa Acute Migraine Drugs Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Acute Migraine Drugs Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Acute Migraine Drugs Business 10.1 GSK 10.1.1 GSK Corporation Information 10.1.2 GSK Introduction and Business Overview 10.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.1.4 GSK Acute Migraine Drugs Products Offered 10.1.5 GSK Recent Development 10.2 Teva 10.2.1 Teva Corporation Information 10.2.2 Teva Introduction and Business Overview 10.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.2.4 Teva Acute Migraine Drugs Products Offered 10.2.5 Teva Recent Development 10.3 Pfizer 10.3.1 Pfizer Corporation Information 10.3.2 Pfizer Introduction and Business Overview 10.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.3.4 Pfizer Acute Migraine Drugs Products Offered 10.3.5 Pfizer Recent Development 10.4 Novartis 10.4.1 Novartis Corporation Information 10.4.2 Novartis Introduction and Business Overview 10.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.4.4 Novartis Acute Migraine Drugs Products Offered 10.4.5 Novartis Recent Development 10.5 Sun Pharma 10.5.1 Sun Pharma Corporation Information 10.5.2 Sun Pharma Introduction and Business Overview 10.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.5.4 Sun Pharma Acute Migraine Drugs Products Offered 10.5.5 Sun Pharma Recent Development 10.6 Grunenthal 10.6.1 Grunenthal Corporation Information 10.6.2 Grunenthal Introduction and Business Overview 10.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.6.4 Grunenthal Acute Migraine Drugs Products Offered 10.6.5 Grunenthal Recent Development 10.7 Endo Pharmaceuticals 10.7.1 Endo Pharmaceuticals Corporation Information 10.7.2 Endo Pharmaceuticals Introduction and Business Overview 10.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered 10.7.5 Endo Pharmaceuticals Recent Development 10.8 Merck 10.8.1 Merck Corporation Information 10.8.2 Merck Introduction and Business Overview 10.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.8.4 Merck Acute Migraine Drugs Products Offered 10.8.5 Merck Recent Development 10.9 J & J 10.9.1 J & J Corporation Information 10.9.2 J & J Introduction and Business Overview 10.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2016-2021) 10.9.4 J & J Acute Migraine Drugs Products Offered 10.9.5 J & J Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Acute Migraine Drugs Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Acute Migraine Drugs Industrial Chain Analysis 11.4 Acute Migraine Drugs Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Acute Migraine Drugs Distributors 12.3 Acute Migraine Drugs Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of Triptans Table 2. Major Company of NSAIDs Table 3. Major Company of Others Table 4. Global Acute Migraine Drugs Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 6. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2016-2021) Table 7. Global Acute Migraine Drugs Sales by Type (2016-2021) & (US& Million) Table 8. Global Acute Migraine Drugs Market Share in Value by Type (2016-2021) Table 9. Global Acute Migraine Drugs Price by Type (2016-2021) & (USD/Unit) Table 10. Global Acute Migraine Drugs Sales by Type (2022-2027) & (K Unit) Table 11. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2022-2027) Table 12. Global Acute Migraine Drugs Sales by Type (2022-2027) & (US$ Million) Table 13. Global Acute Migraine Drugs Sales Market Share in Value by Type (2022-2027) Table 14. Global Acute Migraine Drugs Price by Type (2022-2027) & (USD/Unit) Table 15. North America Acute Migraine Drugs Sales by Type (2016-2021) & (K Unit) Table 16. North America Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million) Table 17. Europe Acute Migraine Drugs Sales (K Unit) by Type (2016-2021) Table 18. Europe Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million) Table 19. Asia-Pacific Acute Migraine Drugs Sales (K Unit) by Type (2016-2021) Table 20. Asia-Pacific Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million) Table 21. Latin America Acute Migraine Drugs Sales (K Unit) by Type (2016-2021) Table 22. Latin America Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million) Table 23. Middle East and Africa Acute Migraine Drugs Sales (K Unit) by Type (2016-2021) Table 24. Middle East and Africa Acute Migraine Drugs Sales by Type (2016-2021) & (US$ Million) Table 25. Global Acute Migraine Drugs Sales by Company (2016-2021) & (K Unit) Table 26. Global Acute Migraine Drugs Sales Share by Company (2016-2021) Table 27. Global Acute Migraine Drugs Revenue by Company (2016-2021) & (US$ Million) Table 28. Global Acute Migraine Drugs Revenue Share by Company (2016-2021) Table 29. Global Market Acute Migraine Drugs Price by Company (2016-2021) & (USD/Unit) Table 30. Global Acute Migraine Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2020 Table 33. Date of Key Manufacturers Enter into Acute Migraine Drugs Market Table 34. Key Manufacturers Acute Migraine Drugs Product Type Table 35. Mergers & Acquisitions, Expansion Plans Table 36. Global Acute Migraine Drugs Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 37. Global Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 38. Global Acute Migraine Drugs Sales Market Share in Volume by Region (2016-2021) Table 39. Global Acute Migraine Drugs Sales by Region (2016-2021) & (US$ Million) Table 40. Global Acute Migraine Drugs Sales Market Share in Value by Region (2016-2021) Table 41. Global Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 42. Global Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit) Table 43. Global Acute Migraine Drugs Sales Market Share in Volume by Region (2022-2027) Table 44. Global Acute Migraine Drugs Sales by Region (2022-2027) & (US$ Million) Table 45. Global Acute Migraine Drugs Sales Market Share in Value by Region (2022-2027) Table 46. Global Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2022-2027) Table 47. Global Acute Migraine Drugs Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 48. Global Acute Migraine Drugs Sales by Application (2016-2021) & (K Unit) Table 49. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2016-2021) Table 50. Global Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 51. Global Acute Migraine Drugs Sales Market Share in Value by Application (2016-2021) Table 52. Global Acute Migraine Drugs Price by Application (2016-2021) & (USD/Unit) Table 53. Global Acute Migraine Drugs Sales by Application (2022-2027) & (K Unit) Table 54. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2022-2027) Table 55. Global Acute Migraine Drugs Sales by Application (2022-2027) & (US$ Million) Table 56. Global Acute Migraine Drugs Sales Market Share in Value by Application (2022-2027) Table 57. Global Acute Migraine Drugs Price by Application (2022-2027) & (USD/Unit) Table 58. North America Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 59. North America Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 60. North America Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Table 61. Europe Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 62. Europe Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 63. Europe Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Table 64. Asia-Pacific Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 65. Asia-Pacific Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 66. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Table 67. Latin America Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 68. Latin America Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 69. Latin America Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Table 70. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) (K Unit) Table 71. Middle East and Africa Acute Migraine Drugs Sales by Application (2016-2021) & (US$ Million) Table 72. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Table 73. North America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 74. North America Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021) Table 75. North America Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million) Table 76. North America Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021) Table 77. North America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 78. North America Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027) Table 79. North America Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million) Table 80. North America Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027) Table 81. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 82. Europe Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021) Table 83. Europe Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million) Table 84. Europe Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021) Table 85. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 86. Europe Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027) Table 87. Europe Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million) Table 88. Europe Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027) Table 89. Asia-Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (K Unit) Table 90. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Region (2016-2021) Table 91. Asia-Pacific Acute Migraine Drugs Sales by Region (2016-2021) & (US$ Million) Table 92. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Region (2016-2021) Table 93. Asia-Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (K Unit) Table 94. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Region (2022-2027) Table 95. Asia-Pacific Acute Migraine Drugs Sales by Region (2022-2027) & (US$ Million) Table 96. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Region (2022-2027) Table 97. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 98. Latin America Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021) Table 99. Latin America Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million) Table 100. Latin America Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021) Table 101. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 102. Latin America Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027) Table 103. Latin America Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million) Table 104. Latin America Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027) Table 105. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (K Unit) Table 106. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Country (2016-2021) Table 107. Middle East and Africa Acute Migraine Drugs Sales by Country (2016-2021) & (US$ Million) Table 108. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Country (2016-2021) Table 109. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (K Unit) Table 110. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Country (2022-2027) Table 111. Middle East and Africa Acute Migraine Drugs Sales by Country (2022-2027) & (US$ Million) Table 112. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Country (2022-2027) Table 113. GSK Corporation Information Table 114. GSK Introduction and Business Overview Table 115. GSK Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 116. GSK Acute Migraine Drugs Product Table 117. GSK Recent Development Table 118. Teva Corporation Information Table 119. Teva Introduction and Business Overview Table 120. Teva Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 121. Teva Acute Migraine Drugs Product Table 122. Teva Recent Development Table 123. Pfizer Corporation Information Table 124. Pfizer Introduction and Business Overview Table 125. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 126. Pfizer Acute Migraine Drugs Product Table 127. Pfizer Recent Development Table 128. Novartis Corporation Information Table 129. Novartis Introduction and Business Overview Table 130. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 131. Novartis Acute Migraine Drugs Product Table 132. Novartis Recent Development Table 133. Sun Pharma Corporation Information Table 134. Sun Pharma Introduction and Business Overview Table 135. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 136. Sun Pharma Acute Migraine Drugs Product Table 137. Sun Pharma Recent Development Table 138. Grunenthal Corporation Information Table 139. Grunenthal Introduction and Business Overview Table 140. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 141. Grunenthal Acute Migraine Drugs Product Table 142. Grunenthal Recent Development Table 143. Endo Pharmaceuticals Corporation Information Table 144. Endo Pharmaceuticals Introduction and Business Overview Table 145. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 146. Endo Pharmaceuticals Acute Migraine Drugs Product Table 147. Endo Pharmaceuticals Recent Development Table 148. Merck Corporation Information Table 149. Merck Introduction and Business Overview Table 150. Merck Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 151. Merck Acute Migraine Drugs Product Table 152. Merck Recent Development Table 153. J & J Corporation Information Table 154. J & J Introduction and Business Overview Table 155. J & J Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021) Table 156. J & J Acute Migraine Drugs Product Table 157. J & J Recent Development Table 158. Key Raw Materials Lists Table 159. Raw Materials Key Suppliers Lists Table 160. Acute Migraine Drugs Market Trends Table 161. Acute Migraine Drugs Market Drivers Table 162. Acute Migraine Drugs Market Challenges Table 163. Acute Migraine Drugs Market Restraints Table 164. Acute Migraine Drugs Distributors List Table 165. Acute Migraine Drugs Downstream Customers Table 166. Research Programs/Design for This Report Table 167. Key Data Information from Secondary Sources Table 168. Key Data Information from Primary Sources List of Figures Figure 1. Acute Migraine Drugs Product Picture Figure 2. Global Acute Migraine Drugs Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Acute Migraine Drugs Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Acute Migraine Drugs Sales Status and Outlook (2016-2027) & (K Unit) Figure 5. Product Picture of Triptans Figure 6. Global Triptans Sales YoY Growth (2016-2021) & (K Unit) Figure 7. Product Picture of NSAIDs Figure 8. Global NSAIDs Sales YoY Growth (2016-2021) & (K Unit) Figure 9. Product Picture of Others Figure 10. Global Others Sales YoY Growth (2016-2021) & (K Unit) Figure 11. Global Acute Migraine Drugs Sales by Type (2016-2027) & (US$ Million) Figure 12. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2016-2021) Figure 13. Global Acute Migraine Drugs Sales Market Share in Value by Type (2016-2021) Figure 14. Global Acute Migraine Drugs Sales Market Share in Volume by Type (2022-2027) Figure 15. Global Acute Migraine Drugs Sales Market Share in Value by Type (2022-2027) Figure 16. North America Acute Migraine Drugs Sales Market Share in Volume by Type in 2020 Figure 17. North America Acute Migraine Drugs Sales Market Share in Value by Type in 2020 Figure 18. Europe Acute Migraine Drugs Sales Market Share in Volume by Type in 2020 Figure 19. Europe Acute Migraine Drugs Sales Market Share in Value by Type in 2020 Figure 20. Asia-Pacific Acute Migraine Drugs Sales Market Share in Volume by Type in 2020 Figure 21. Asia-Pacific Acute Migraine Drugs Sales Market Share in Value by Type in 2020 Figure 22. Latin America Acute Migraine Drugs Sales Market Share in Volume by Type in 2020 Figure 23. Latin America Acute Migraine Drugs Sales Market Share in Value by Type in 2020 Figure 24. Middle East and Africa Acute Migraine Drugs Sales Market Share in Volume by Type in 2020 Figure 25. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Type in 2020 Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Migraine Drugs Sales in 2020 Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Acute Migraine Drugs Revenue in 2020 Figure 28. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 29. Product Picture of Hospital Pharmacies Figure 30. Global Hospital Pharmacies Sales YoY Growth (2016-2027) & (K Unit) Figure 31. Product Picture of Drug Stores Figure 32. Global Drug Stores Sales YoY Growth (2016-2027) & (K Unit) Figure 33. Global Acute Migraine Drugs Sales by Application (2016-2027) & (US$ Million) Figure 34. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2016-2021) Figure 35. Global Acute Migraine Drugs Sales Market Share in Value by Application (2016-2021) Figure 36. Global Acute Migraine Drugs Sales Market Share in Volume by Application (2022-2027) Figure 37. North America Acute Migraine Drugs Sales Market Share in Volume by Application in 2020 Figure 38. Latin America Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Figure 39. Middle East and Africa Acute Migraine Drugs Sales Market Share in Value by Application in 2020 Figure 40. Key Raw Materials Price Figure 41. Acute Migraine Drugs Manufacturing Cost Structure Figure 42. Acute Migraine Drugs Industrial Chain Analysis Figure 43. Channels of Distribution Figure 44. Distributors Profiles Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

GSK Teva Pfizer Novartis Sun Pharma Grunenthal Endo Pharmaceuticals Merck J & J